Finance

Beta
Lists
SPH:WSE
Sopharma AD
PLN 8.02
0.00%
(0.00) 1D
Jun 11, 3:20:02 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SPH...
Mkt. cap
1.02B
Avg. vol.
819.00
Volume
0.00
52-wk high
PLN 16.00
52-wk low
PLN 4.48
Shares outstanding
134.80M
No. of employees
6K
Mkt. cap
1.02B
Avg. vol.
819.00
Volume
0.00
52-wk high
PLN 16.00
52-wk low
PLN 4.48
Shares outstanding
134.80M
No. of employees
6K
News stories
From sources across the web
About Sopharma AD
CEO-
Employees6K
Founded1933
Headquarters-
SectorPharmaceutical industry
Websitesopharmagroup.com
Previous reportsAll values in BGN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BGN
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
644.06M
637.00M
641.57M
710.03M
Cost of goods sold
492.38M
493.21M
484.05M
537.91M
Cost of revenue
492.38M
493.21M
484.05M
537.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90.69M
96.32M
91.96M
108.78M
Operating expense
110.48M
115.05M
113.18M
151.56M
Total operating expenses
602.85M
608.26M
597.23M
689.48M
Operating income
41.21M
28.75M
44.35M
20.55M
Other non operating income
-486.00K
-309.00K
1.54M
-2.14M
EBT including unusual items
49.36M
36.69M
45.95M
25.24M
EBT excluding unusual items
49.36M
31.35M
48.79M
23.26M
Income tax expense
5.44M
4.58M
4.93M
711.00K
Effective tax rate
11.02%
12.49%
10.72%
2.82%
Other operating expenses
2.72M
1.16M
2.24M
17.30M
Net income
40.33M
30.07M
40.38M
22.74M
Net profit margin
6.26%
4.72%
6.29%
3.20%
Earnings per share
-
-
-
-
Interest and investment income
785.00K
829.00K
1.24M
978.00K
Interest expense
-4.62M
-5.41M
-5.63M
-5.83M
Net interest expenses
-3.84M
-4.58M
-4.40M
-4.86M
Depreciation and amortization charges
17.07M
17.57M
18.38M
26.01M
EBITDA
56.30M
46.04M
73.29M
30.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer